Goldman Sachs Call 260 PGR 21.06..../ DE000GG7FE01 /
2024-05-29 10:50:58 AM | Chg.0.000 | Bid2024-05-29 | Ask2024-05-29 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.001EUR | 0.00% | 0.001 Bid Size: 10,000 |
0.300 Ask Size: 1,000 |
Progressive Corporat... | 260.00 USD | 2024-06-21 | Call |
GlobeNewswire
2:00 PM
Intercept Announces New Data to be Presented at the European Association for the Study of the Liver ...
GlobeNewswire
2:00 PM
Spinogenix Announces FDA Clearance of IND Application for SPG302, a Novel Therapy for the Treatment ...
GlobeNewswire
1:30 PM
Vyluma Announces Marketing Authorization Application Validation for the European Union
GlobeNewswire
1:00 PM
ACELYRIN, INC. Announces Lonigutamab Phase 1/2 Proof-Of-Concept Data to be Shared During Late-Breaki...
GlobeNewswire
05-28
Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin...
GlobeNewswire
05-28
Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
GlobeNewswire
05-28
TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple ...
GlobeNewswire
05-25
Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b OR...
GlobeNewswire
05-24
Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Act...
GlobeNewswire
05-24
BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024
GlobeNewswire
05-23
Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Adv...
GlobeNewswire
05-21
Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data ...
GlobeNewswire
05-20
Avalyn Presents Clinical Data on AP01 for Pulmonary Fibrosis, Including Long-Term Efficacy and Imagi...
GlobeNewswire
05-20
APRINOIA Therapeutics Announces Fast Track Designation Granted by U.S. FDA to APN-1607 (florzolotau)...
GlobeNewswire
05-20
Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Tria...
GlobeNewswire
05-20
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Preventio...
GlobeNewswire
05-16
BMW unveils The BMW XM Mystique Allure, a one-of-a-kind luxury vehicle inspired by the iconic superm...
GlobeNewswire
05-15
Eyenovia Reports First Quarter 2024 Financial Results and Provides Updates on its Myopia Phase III P...
GlobeNewswire
05-14
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment...